Metraipolis › archive › dc_38c4fc8455bb

Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma — Europe PMC PMID:41210166

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41210166
DOI
10.1016/j.omtm.2025.101614
License (as archived)
solo-consultazione
Archived
2026-11-09T09:49:00.848Z
SHA-256 of the archived text
bc441c5b47d63a6baafdcc1ea78f8e7c368fb537a5ee0c101a8815f878445eab
Stable URL of this page
https://metraipolis.com/documento/dc_38c4fc8455bb

How to cite

Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma — Europe PMC PMID:41210166 — Europe PMC (en), https://europepmc.org/article/MED/41210166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38c4fc8455bb (Metraipolis archive dc_38c4fc8455bb, sha256 bc441c5b47d63a6baafdcc1ea78f8e7c368fb537a5ee0c101a8815f878445eab)
BibTeX
@misc{dc38c4fc8455bb,
  title = {Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma — Europe PMC PMID:41210166},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41210166},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38c4fc8455bb; sha256 bc441c5b47d63a6baafdcc1ea78f8e7c368fb537a5ee0c101a8815f878445eab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210166. Agents can read the archived copy with the MCP tool read_document.